Confidential Treatment Requested under 17 C.F.R. Sections 200.80(b)(4) and 230.406 andAssignment and Exclusive Licence • May 1st, 2015 • Adaptimmune Therapeutics PLC • Biological products, (no disgnostic substances) • England and Wales
Contract Type FiledMay 1st, 2015 Company Industry Jurisdiction
Confidential Treatment Requested under 17 C.F.R. Sections 200.80(b)(4) and 230.406 andAssignment and Exclusive Licence • April 27th, 2015 • Adaptimmune Therapeutics PLC • Biological products, (no disgnostic substances) • England and Wales
Contract Type FiledApril 27th, 2015 Company Industry Jurisdiction